Search Results
Slidesets
Managing transition from paediatric to adolescent to adult HIV care- Allyson McKenny, MD
Presented at:
INTEREST 2017
Slidesets
Debate: Can we eliminate HCV from Africa?- Richard Njouom, PhD
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Aramchol for NASH and beyond: From scientific rationale to clinical development- Carol Brosgart
Presented at:
HEP DART 2017
Slidesets
Immunological Editing to Drive HBsAg Production from Integrated HBV DNA vs. Infected HepatocTyes_Adam Gehring.pdf
Presented at:
International Workshop on HBV Cure 2024
Abstracts
TB, a ticking time bomb Among the key population-lessons learnt from Kenya PWID program
F. Ochieng
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Slidesets
From Pandemic Response to Pandemic Recovery - Opportunities for Viral Hepatitis Elimination - John Ward, MD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Dr. Dominique Costagliola - Improving European Healthcare - Lessons Learned from the COVID-19 Pandemic
Presented at:
European Meeting on HIV & Hepatitis 2021
Slidesets
Biomarkers: what can be learned from type 2 diabetes | Manu Chakravarthy, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2016
Abstracts
Are MSM community ready for HIV self-testing reader? Results from a cross-sectional study
G. Marley
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Slidesets
New Data From Combination Trials for Chronic Hepatitis B - P. Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2021